Evidence map›Paper›PMID 27092946›Full record

ArticlePloS one2016

Investigating CFTR and KCa3.1 Protein/Protein Interactions.

Hélène Klein, Asmahan Abu-Arish, Nguyen Thu Ngan Trinh, Yishan Luo, Paul W Wiseman, John W Hanrahan, Emmanuelle Brochiero, Rémy Sauvé

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Functional Consequences of CFTR Interactions in Cystic Fibrosis.International journal of molecular sciences · 2024
    Review
  4. Review
  5. Article
  6. The actions of NME1/NDPK-A and NME2/NDPK-B as protein kinases.Laboratory investigation; a journal of technical methods and pathology · 2018
    Review
  7. Synergy of cAMP and calcium signaling pathways in CFTR regulation.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hélène KleinDépartement de Physiologie moléculaire et intégrative and Membrane Protein Research Group, Université de Montréal, Montréal, QC, Canada, H3C 3J7.
Asmahan Abu-ArishDepartment of Physiology, McGill University, Montréal, QC, Canada, H3G 1Y6.
Nguyen Thu Ngan TrinhCentre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Tour Viger, 900 rue Saint-Denis, Montréal, QC, Canada, H2X 0A9.
Yishan LuoDepartment of Physiology, McGill University, Montréal, QC, Canada, H3G 1Y6.
Paul W WisemanChemistry & Physics, McGill University, Montreal, QC, Canada, H3G 1Y6.
John W HanrahanDepartment of Physiology, McGill University, Montréal, QC, Canada, H3G 1Y6.
Emmanuelle BrochieroCentre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Tour Viger, 900 rue Saint-Denis, Montréal, QC, Canada, H2X 0A9.
Rémy SauvéDépartement de Physiologie moléculaire et intégrative and Membrane Protein Research Group, Université de Montréal, Montréal, QC, Canada, H3C 3J7.
McGill University · CAUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

In epithelia, Cl- channels play a prominent role in fluid and electrolyte transport. Of particular importance is the cAMP-dependent cystic fibrosis transmembrane conductance regulator Cl- channel (CFTR) with mutations of the CFTR encoding gene causing cystic fibrosis. The bulk transepithelial transport of Cl- ions and electrolytes needs however to be coupled to an increase in K+ conductance in order to recycle K+ and maintain an electrical driving force for anion exit across the apical membrane. In several epithelia, this K+ efflux is ensured by K+ channels, including KCa3.1, which is expressed at both the apical and basolateral membranes. We show here for the first time that CFTR and KCa3.1 can physically interact. We first performed a two-hybrid screen to identify which KCa3.1 cytosolic domains might mediate an interaction with CFTR. Our results showed that both the N-terminal fragment M1-M40 of KCa3.1 and part of the KCa3.1 calmodulin binding domain (residues L345-A400) interact with the NBD2 segment (G1237-Y1420) and C- region of CFTR (residues T1387-L1480), respectively. An association of CFTR and F508del-CFTR with KCa3.1 was further confirmed in co-immunoprecipitation experiments demonstrating the formation of immunoprecipitable CFTR/KCa3.1 complexes in CFBE cells. Co-expression of KCa3.1 and CFTR in HEK cells did not impact CFTR expression at the cell surface, and KCa3.1 trafficking appeared independent of CFTR stimulation. Finally, evidence is presented through cross-correlation spectroscopy measurements that KCa3.1 and CFTR colocalize at the plasma membrane and that KCa3.1 channels tend to aggregate consequent to an enhanced interaction with CFTR channels at the plasma membrane following an increase in intracellular Ca2+ concentration. Altogether, these results suggest 1) that the physical interaction KCa3.1/CFTR can occur early during the biogenesis of both proteins and 2) that KCa3.1 and CFTR form a dynamic complex, the formation of which depends on internal Ca2+.

Indexed as

CalciumCell LineCell MembraneChloride ChannelsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorEpithelial CellsEpitheliumHumansIntermediate-Conductance Calcium-Activated Potassium ChannelsIon TransportMutationPotassiumProtein BindingProtein Interaction MapsCalciumCFTR protein, humanChloride ChannelsCystic Fibrosis Transmembrane Conductance RegulatorIntermediate-Conductance Calcium-Activated Potassium ChannelsKCNN4 protein, humanPotassium

Identifiers

PMID27092946
PMCPMC4836752
OpenAlexW2336732532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.